Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Research Fellow







Commonwealth BuildingHammersmith Campus





Publication Type

1 results found

Hennah L, Seckl M, Ghorani E, 2023, Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy., Int J Gynecol Cancer, Vol: 33, Pages: 414-419

The discovery that anti-programmed death-1 antibody (anti-PD-1) immunotherapy can cure patients with multidrug-resistant gestational trophoblastic neoplasia provides a new powerful and low toxicity treatment. This heralds an era within which the majority of patients, including those with previously difficult to treat disease, can expect to achieve long-term remission. This development should prompt a rethink of how patients with this rare disease are managed, focusing on maximizing cure rate with minimal exposure to toxic chemotherapy.

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: respub-action=search.html&id=00331768&limit=30&person=true